Analysis of the chemotherapy effect of albumin-bound paclitaxel combined with pirarubicin and cyclophosphamide on breast cancer and the effects of PCR, ORR, and CBR
Albumin-bound paclitaxel combined with pirarubicin and cyclophosphamide is a safe regimen that can further enhance the effect of neoadjuvant chemotherapy in the treatment of breast cancer, and it has a certain value for dissemination in the treatment of breast cancer can further enhance the effect of neoadjuvant chemotherapy in patients, which is of certain value for clinical promotion.
Authors
- KeWei Gong (ORCID: https://orcid.org/0000-0002-3890-3761)
- Youzhong Liu (ORCID: https://orcid.org/0000-0002-1449-3841)
- Songlin Yuan
- Yong Xu (ORCID: https://orcid.org/0000-0002-2804-2611)
Institutions
- Central South University (CN)
- The First People's Hospital of Changde (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2025-02-21
- DOI
- https://doi.org/10.12669/pjms.41.3.9861
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00